 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 June 1999 | Volume 130 Issue 12 | Pages 1005-1013
Bayesian inference is usually presented as a method for determining how scientific belief should be modified by data. Although Bayesian methodology has been one of the most active areas of statistical development in the past 20 years, medical researchers have been reluctant to embrace what they perceive as a subjective approach to data analysis. It is little understood that Bayesian methods have a data-based core, which can be used as a calculus of evidence. This core is the Bayes factor, which in its simplest form is also called a likelihood ratio. The minimum Bayes factor is objective and can be used in lieu of the P value as a measure of the evidential strength. Unlike P values, Bayes factors have a sound theoretical foundation and an interpretation that allows their use in both inference and decision making. Bayes factors show that P values greatly overstate the evidence against the null hypothesis. Most important, Bayes factors require the addition of background knowledge to be transformed into inferences—probabilities that a given conclusion is right or wrong. They make the distinction clear between experimental evidence and inferential conclusions while providing a framework in which to combine prior with current evidence.
Author and Article Information
From Johns Hopkins University School of Medicine, Baltimore, Maryland.
Acknowledgments: The author thanks Dan Heitjan, Russell Localio, Harold Lehmann, and Michael Berkwitz for helpful comments on earlier versions of this article. The views expressed are the sole responsibility of the author.
Requests for Reprints: Steven N. Goodman, MD, PhD, Johns Hopkins University, 550 North Broadway, Suite 409, Baltimore, MD 21205; e-mail, sgoodman{at}jhu.edu. ACADEMIA AND CLINIC
Toward Evidence-Based Medical Statistics. 2: The Bayes Factor
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  P. A. Anderson, P. C. McCormick, and P. D. Angevine Randomized Controlled Trials of the Treatment of Lumbar Disk Herniation: 1983-2007 J. Am. Acad. Ortho. Surg., October 1, 2008; 16(10): 566 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Jiang, X.-L. Wu, M. Zhang, J. J. Michal, and R. W. Wright Jr. The Complementary Neighborhood Patterns and Methylation-to-Mutation Likelihood Structures of 15,110 Single-Nucleotide Polymorphisms in the Bovine Genome Genetics, September 1, 2008; 180(1): 639 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. A. Ioannidis Effect of Formal Statistical Significance on the Credibility of Observational Associations Am. J. Epidemiol., August 15, 2008; 168(4): 374 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Fauchere, C. Dame, R. Vonthein, B. Koller, S. Arri, M. Wolf, and H. U. Bucher An Approach to Using Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants Pediatrics, August 1, 2008; 122(2): 375 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Graber, A. S. Lauring, and P. V. Chin-Hong A Stitch in Time -- A 64-year-old man with a history of coronary artery disease and peripheral vascular disease was admitted to the hospital with a several-month history of fevers, chills, and fatigue N. Engl. J. Med., September 6, 2007; 357(10): 1029 - 1034. [Full Text] [PDF]
|
|
|
|
 |
|
 F Keller, G Allert, H Baitsch, G Sponholz, and Ethics in Medicine Working Group at the University Discourse ethics in practical medicine Med. Humanit., December 1, 2006; 32(2): 99 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W Zhang, M Doherty, E Pascual, T Bardin, V Barskova, P Conaghan, J Gerster, J Jacobs, B Leeb, F Liote, et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT) Ann Rheum Dis, October 1, 2006; 65(10): 1301 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Steinberg Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy J. Lipid Res., July 1, 2006; 47(7): 1339 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Vladusich, M. P. Lucassen, and F. W. Cornelissen Do Cortical Neurons Process Luminance or Contrast to Encode Surface Properties? J Neurophysiol, April 1, 2006; 95(4): 2638 - 2649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Clouse, J. Chen, H. M. Krumholz, M. E. Clouse, J. Chen, and H. M. Krumholz Noninvasive Screening for Coronary Artery Disease With Computed Tomography Is Useful Circulation, January 3, 2006; 113(1): 125 - 146. [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. West Contradictions in Highly Cited Clinical Research JAMA, December 7, 2005; 294(21): 2695 - 2695. [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Robinson, B. Smith, N. Maheshwari, and H. Schrott Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?: A Meta-Regression Analysis J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1855 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Stengel, K. Bauwens, G. Rademacher, S. Mutze, and A. Ekkernkamp Association between Compliance with Methodological Standards of Diagnostic Research and Reported Test Accuracy: Meta-Analysis of Focused Assessment of US for Trauma Radiology, July 1, 2005; 236(1): 102 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Helfand A Look Back...and Ahead Med Decis Making, January 1, 2005; 25(1): 8 - 10. [PDF]
|
|
|
|
 |
|
 C. M. R. Kitchen, S. Philpott, H. Burger, B. Weiser, K. Anastos, and M. A. Suchard Evolution of Human Immunodeficiency Virus Type 1 Coreceptor Usage during Antiretroviral Therapy: a Bayesian Approach J. Virol., October 15, 2004; 78(20): 11296 - 11302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-J. Kim, J. S. Bertino Jr., T. A. Erb, P. L. Jenkins, and A. N. Nafziger Application of Bayes Theorem to Aminoglycoside-Associated Nephrotoxicity: Comparison of Extended-Interval Dosing, Individualized Pharmacokinetic Monitoring, and Multiple-Daily Dosing J. Clin. Pharmacol., July 1, 2004; 44(7): 696 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wacholder, S. Chanock, M. Garcia-Closas, L. El ghormli, and N. Rothman Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies J Natl Cancer Inst, March 17, 2004; 96(6): 434 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bellomo, D. L. Hare, and B. F. Buxton Reply to the Editor J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 892 - 893. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Goodman Commentary: The P-value, devalued Int. J. Epidemiol., October 1, 2003; 32(5): 699 - 702. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jeffery, S. Holgate, and S. Wenzel Methods for the Assessment of Endobronchial Biopsies in Clinical Research: Application to Studies of Pathogenesis and the Effects of Treatment Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): S1 - 17. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hupert, G. M.L. Bearman, A. I. Mushlin, and M. A. Callahan Accuracy of Screening for Inhalational Anthrax after a Bioterrorist Attack Ann Intern Med, September 2, 2003; 139(5_Part_1): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J Hoggatt Commentary: Vitamin supplement use and confounding by lifestyle Int. J. Epidemiol., August 1, 2003; 32(4): 553 - 555. [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Estey and P. F. Thall New designs for phase 2 clinical trials Blood, July 15, 2003; 102(2): 442 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Brophy, P. Belisle, and L. Joseph Evidence for Use of Coronary Stents: A Hierarchical Bayesian Meta-Analysis Ann Intern Med, May 20, 2003; 138(10): 777 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cummings and F. P. Rivara Reporting Statistical Information in Medical Journal Articles Arch Pediatr Adolesc Med, April 1, 2003; 157(4): 321 - 324. [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Walford, D. Mock, R. Verdery, and T. MacCallum Calorie Restriction in Biosphere 2: Alterations in Physiologic, Hematologic, Hormonal, and Biochemical Parameters in Humans Restricted for a 2-Year Period J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2002; 57(6): B211 - 224. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. E. Feasby, J. Kennedy, H. Quan, W. A. Ghali, E. L. Hannan, A. J. Popp, M. R. Chassin, and E. Halm Outcomes in Carotid Endarterectomy Performed by Vascular Surgeons or Neurosurgeons * Response Stroke, June 1, 2002; 33(6): 1458 - 1458. [Full Text] [PDF]
|
|
|
|
|
|
J. E. Haberer, J. H. Ix, and L. M. Tierney Jr. One Foot Away N. Engl. J. Med., May 2, 2002; 346(18): 1394 - 1397. [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Sullivan, L. J. Eaves, K. S. Kendler, and M. C. Neale Genetic Case-Control Association Studies in Neuropsychiatry Arch Gen Psychiatry, November 1, 2001; 58(11): 1015 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A C Sterne, G. D. Smith, and D R Cox Sifting the evidence--what's wrong with significance tests? Physical Therapy, August 1, 2001; 81(8): 1464 - 1469. [Full Text] [PDF]
|
|
|
|
|
|
D. B. Dunson Commentary: Practical Advantages of Bayesian Analysis of Epidemiologic Data Am. J. Epidemiol., June 15, 2001; 153(12): 1222 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V Sintchenko and G L Gilbert Evidence based diagnostic microbiology: has its time come? J. Clin. Pathol., June 1, 2001; 54(6): 441 - 442. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A C Sterne, G. D. Smith, and D R Cox Sifting the evidence{---}what's wrong with significance tests? Another comment on the role of statistical methods BMJ, January 27, 2001; 322(7280): 226 - 231. [Full Text]
|
|
|
|
 |
|
 D. A. Sandweiss P Value Out of Control Arch Intern Med, June 26, 2000; 160(12): 1872 - 1872. [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Lehmann and S. N. Goodman Bayesian Communication: A Clinically Significant Paradigm for Electronic Publication J. Am. Med. Inform. Assoc., May 1, 2000; 7(3): 254 - 266. [Abstract] [Full Text]
|
|
Article
